CLINICAL ROLE -
Trends in First-Year Utilization Costs of HIV Medications
HIV is of interest among many in managed care. This paper focuses on the costs and demographic characteristics associated with new HIV therapy initiators.
Prescription Utilization of the Oral Anticoagulants
New and forthcoming oral anticoagulants, which do not require prothrombin time monitoring, will offer patients and providers additional therapeutic options.
Initial Prescription Utilization of the New Hepatitis C Agents
Incivek and Victrelis, approved for Hepatitis C within weeks of each other in May 2011, look to change the way the disease is treated.
Early View of Ampyra and Gilenya Use by MS Patients
Uptake of the new oral agents gilenya and Ampyra may be expected to increase rapidly in the future, if for largely different reasons.
2 Commerce Drive Cranbury, NJ 08512